News
FDA probes Elevidys after an 8-year-old's death in Brazil; Sarepta and Roche say the death was unrelated to gene therapy ...
Sarepta rebuffed a call from the Food and Drug Administration to halt all shipments of its gene therapy for Duchenne muscular ...
5h
Asianet Newsable on MSNWhy Sarepta Therapeutics Stock Surged Nearly 48% In After-Hours Trading TodayThe FDA concluded that a recent patient death in Brazil was unrelated to Sarepta’s Elevidys treatment, allowing the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results